We are a public investment issuer looking to create substantial value for our shareholders.

We look for and find great opportunities

Blackhawk Growth Corp. is an investment issuer looking to capitalize on market and industry trends that can create substantial value for its shareholders. We look for opportunities all over the globe where we can leverage our knowledge, expertise, and experience to deliver substantial growth for our companies and our investors.
View Our Portfolio

Our Portfolio

Blackhawk drives its growth by investing in equity and debt instruments of companies and generating positive returns with minimal risk for shareholders. The company’s strategy is focused on investing in multiple companies across a variety of sectors across North America.

Blackhawk signed a definitive agreement with Medigen Biotechnology Corporation and TBG Biotechnology Corp. to distribute certain diagnostic products, including an ExProbe SARS-CoV-2 Testing Kit and a SARS-CoV-2 IgG/IgM Rapid Test Kit used in the detection of antibodies associated with COVID-19. Both testing kits are EUA approved by the FDA.

An online clinic that connects doctors to their existing patients and allows new patients near instant access to a doctor from the comfort of their home.

Specializing in preservative-free shelf-stable baked goods. NuWave Foods is a fully licensed commercial kitchen and baked goods manufacturer located in Edmonton Alberta.

Launching edibles into ORBIT using high tech, space-age science

News Releases

View All

Blackhawk Receives Confirmation from Health Canada of Receipt of Interim Order Application and Provides Corporate Update

| News Release | No Comments
Vancouver, British Columbia - TheNewswire - October 19, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (the "Corporation" or "Blackhawk"), is pleased to provide the following corporate update. The Health Canada Interim Order ("IO") application was completed and submitted for the ExProbe SARS-CoV-2 Testing Kit. The Company received confirmation of receipt from Health Canada on October 14, 2020. Even though Blackhawk…

Blackhawk Completes Investment in Psychadelic Development and Wellness Space

| News Release | No Comments
Vancouver, British Columbia - TheNewswire - October 16, 2020 - Blackhawk Growth Corp. (CSE:BLR) (CNSX:BLR.CN) (Frankfurt:0JJ) US (OTC:BLRZF) (the "Company"), is pleased to announce that it has acquired (the "Transaction") all of the outstanding share capital of Trip Pharma Inc. ("Trip Pharma"). Led by Dr. Krista Leicht, Trip Pharma is a privately-held arms-length psychedelic development and wellness company based in…
Click To View


Click To View

Stock Info